- Radiotherapy, a cornerstone of modern cancer treatment involving the use of high-energy radiation to destroy cancer cells, is becoming increasingly vital in South Asia's healthcare landscape as cancer prevalence rises and medical infrastructure evolves across India, Nepal, Bangladesh, and Sri Lanka
- The growing demand for radiotherapy solutions is primarily driven by increasing cancer awareness, government-backed oncology programs, and the establishment of cancer centers equipped with advanced treatment technologies such as linear accelerators and brachytherapy systems
- India dominated the radiotherapy market with the largest revenue share of 75.5% in 2024, supported by a vast network of tertiary hospitals, public-private partnerships, and initiatives under the National Cancer Control Programme, with Tier I and Tier II cities witnessing significant investments in radiotherapy infrastructure
- Bangladesh is expected to be the fastest-growing country in the radiotherapy market during the forecast period due to expanding healthcare access, rising investment in medical technology, and collaborative efforts with international health organizations
- The external beam radiotherapy (EBRT) segment dominated the radiotherapy market with a share of 61% in 2024, owing to its widespread availability, clinical effectiveness, and increasing adoption in both public and private oncology care centers
